[Intra-articular injections of an anti-plasmin agent for the therapy of chronic rheumatoid arthritis]. 1965

M Nakahara, and T Tokita, and T Yoshiwara

UI MeSH Term Description Entries
D007270 Injections, Intra-Articular Methods of delivering drugs into a joint space. Intra Articular Injection,Intraarticular Injection,Injections, Intraarticular,Intra-Articular Injections,Intraarticular Injections,Articular Injection, Intra,Articular Injections, Intra,Injection, Intra Articular,Injection, Intra-Articular,Injection, Intraarticular,Injections, Intra Articular,Intra Articular Injections,Intra-Articular Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000614 Aminocaproates Amino derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the amino caproic acid structure. Aminocaproic Acids,Aminocaproic Acid Derivatives,Aminohexanoates,Aminohexanoic Acid Derivatives,Aminohexanoic Acids,Acid Derivatives, Aminocaproic,Acid Derivatives, Aminohexanoic,Acids, Aminocaproic,Acids, Aminohexanoic,Derivatives, Aminocaproic Acid,Derivatives, Aminohexanoic Acid
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Nakahara, and T Tokita, and T Yoshiwara
January 1959, Rheumatism,
M Nakahara, and T Tokita, and T Yoshiwara
April 2006, Nature clinical practice. Rheumatology,
M Nakahara, and T Tokita, and T Yoshiwara
May 1969, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Nakahara, and T Tokita, and T Yoshiwara
June 1962, Annals of the rheumatic diseases,
M Nakahara, and T Tokita, and T Yoshiwara
November 1964, Annals of physical medicine,
M Nakahara, and T Tokita, and T Yoshiwara
March 1956, Zeitschrift fur arztliche Fortbildung,
M Nakahara, and T Tokita, and T Yoshiwara
January 2014, European review for medical and pharmacological sciences,
M Nakahara, and T Tokita, and T Yoshiwara
January 2005, Nihon rinsho. Japanese journal of clinical medicine,
M Nakahara, and T Tokita, and T Yoshiwara
January 2009, Modern rheumatology,
Copied contents to your clipboard!